The Hydroponics Company Provides Product Update

The Hydroponics Company Limited (ASX:THC) advises that it welcomes the announcement from Health Minister Greg Hunt allowing for the exportation of medicinal cannabis. THC believes that this initiative will foster the development of the local medicinal cannabis industry and expects to see further investment in the opportunities within the Medicinal Cannabis market in Australia.

David Radford CEO of THC said “this Federal Government initiative supports the growth and further investment in Australian medicinal cannabis companies. THC is uniquely placed to both develop the international opportunities that will now open up through our International Partnerships, as well as accelerate the Australian uptake of medicinal cannabis through our National Access Cannabis clinics that we plan to establish, commencing in early 2018.”

The build out of the Company’s growing facility in Queensland is well advanced, and THC remains on track, pending appropriate Government licencing, for a pilot growing program in the first half of 2018, which will underpin development of both the international and domestic supply chains. First commercial cultivation of cannabis will take place once final licensing is in place

THC is on track to import the first medicinal cannabis product range from Endoca early in 2018 and product will be available to eligible medical practitioners via the Authorised Prescriber Scheme and Special Access Scheme. The distribution agreement with Endoca in conjunction with the National Access Cannabis (NAC) clinic model will enable THC to deliver secure, safe, and responsible access to legal medicinal cannabis commencing with an initial selection of high-quality, GMP certified Endoca CBD products (3% CBD oil, 15% CBD oil).


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s